Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal CancerNaohiro Tomita, Tetsuji Takayama, Hideki Ishikawa et al.|International Journal of Clinical Oncology|2021Cited by 157
Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre studyTomoki Yamano, Yoshito Akagi, Shinichi Yamauchi et al.|European Journal of Cancer|2017Cited by 63
Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trialJunichi Koike, Shingo Kameoka, Kimihiko Funahashi et al.|Cancer Chemotherapy and Pharmacology|2017Cited by 50
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)Hideyuki Ishida, Osamu Tsuruta, Tatsuro Yamaguchi et al.|Journal of the Anus Rectum and Colon|2018Cited by 47
Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communicationYoshinori Hoshino, Yuko Kitagawa, Tetsu Hayashida et al.|Molecular Cancer|2014Cited by 30